Molly Allen Christie Brown Cici Chen Sherine Cheung Aron Lau - - PowerPoint PPT Presentation

molly allen christie brown cici chen sherine cheung aron
SMART_READER_LITE
LIVE PREVIEW

Molly Allen Christie Brown Cici Chen Sherine Cheung Aron Lau - - PowerPoint PPT Presentation

Molly Allen Christie Brown Cici Chen Sherine Cheung Aron Lau Marlee Tichenor Madhvi Venkatesh Bing Xia Dirk VandePol Limitations of Current Methods of Parts Manufacture Improve Efficiency by Using Robots and in


slide-1
SLIDE 1

Molly Allen  Christie Brown  Cici Chen  Sherine Cheung  Aron Lau

 Marlee Tichenor  Madhvi Venkatesh  Bing Xia  Dirk VandePol

slide-2
SLIDE 2

Limitations of Current Methods of Parts Manufacture

slide-3
SLIDE 3

Improve Efficiency by Using Robots and in vivo Reactions

slide-4
SLIDE 4

An Automatable Scheme with Reactions that can be done in vivo

Layered Standard Assembly

Layered Standard Assembly

Two-Antibiotic Assembly

Gateway Reaction

SpecR AmpR KanR CamR

slide-5
SLIDE 5

Gateway Reaction: Transfer of Sequences Flanked by att Sites

attR1 attL1 attL2 attR2 attB1 attP1 attP2 attB2

slide-6
SLIDE 6

Biologically Encoding Unit Operations for Transferring Parts

Miniprep Transformation Biochemical Manipulation

Gateway Device Self-Lysis Device Phagemid Device

slide-7
SLIDE 7

Gateway Device: Performing LR Gateway in vivo

Excisionase Integrase Integration Host Factor Temperature Sensitive Promoter

attL attR attB attP Gateway Device

xis int ihfa ihfb

Pts

slide-8
SLIDE 8

Gateway Device Replaces Biochemical Manipulation

ccdA

Chloramphicol Resistance Ampicillin Resistance Kill Device Gateway Device

ccdB xis int

Pts

slide-9
SLIDE 9

Gateway Device Replaces Biochemical Manipulation

ccdA

slide-10
SLIDE 10

Ampicillin and Chloramphenicol Sensitive Contains Lethal ccdB Ampicillin and Chloramphenicol Sensitive Survives

Gateway Device Replaces Biochemical Manipulation

slide-11
SLIDE 11

Plasmid Based Gateway in vivo is very efficient

1 2 3 4 5 6 A B C D E F G H 1 2 3 4 5 6

Colonies spotted on Cm/Amp Desired product Co-transformation Colonies spotted on Spec

Concentrated

1.4% ± 0.8% co-transformation 0.8% ± 0.7% co-transformation

A B C D E F G H 1 2 3 4 5 6 1 2 3 4 5 6

Desired product Co-transformation

1/20 Dilution

Colonies spotted on Cm/Amp

slide-12
SLIDE 12

Lysis Device: Alternative to Miniprep PoPS Lysis Lysis Device vs.

slide-13
SLIDE 13

Natural Lambda Phage Lysis Pathway at Work

Inner Membrane Outer Membrane Periplasm Lysozyme Holin Antiholin

slide-14
SLIDE 14

Lambda Phage Lysis: Governing Equations

slide-15
SLIDE 15

Lambda Phage Lysis: Steady-State Solution & Parameters

Holin Production

Anti-Holin Production Holin / Anti-Holin Interaction

slide-16
SLIDE 16

Lambda Phage Lysis: Reaching the Critical Holin Concentration

Critical Holin Concentration

slide-17
SLIDE 17

Lambda Phage Lysis: Reaching the Critical Holin Concentration

Critical Holin Concentration

slide-18
SLIDE 18

Lysis Device: Alternative to Miniprep PoPS Lysis Lysis Device

R S Rz

PBAD Pcon

Lysozyme Holin Antiholin Inducible Promoter Constitutive Promoter

slide-19
SLIDE 19

Arabinose-Induced Lysis Device at Work

Induced with Arabinose Without Arabinose 1 hour after induction at mid-log

slide-20
SLIDE 20

Lysis Device Results Show Critical Arabinose Concentration

slide-21
SLIDE 21

Lysis Device Replaces Miniprep in Plasmid Based Gateway

ccdA

Chloramphicol Resistance Ampicillin Resistance Kill Device Gateway Device

ccdB xis int R S Rz

Self-Lysis Device

slide-22
SLIDE 22

ccdA

Lysis Device Replaces Miniprep in Plasmid Based Gateway

slide-23
SLIDE 23

Survives

Lysis Device Replaces Miniprep in Plasmid Based Gateway

slide-24
SLIDE 24

Successful use of Lysis Device for Gateway in vivo

Gateway Device + Lysis Device in Assembly Vector Cam/Amp Spec

slide-25
SLIDE 25

PoPS P1 Particles Phagemid Device* vs.

* Phagemid Device built by Will Deloache

Phagemid Device: Alternative to Miniprep and Transformation

slide-26
SLIDE 26

Phagemid Device Replaces Minipreps and Transformation

Phagemid Device Gateway Device

slide-27
SLIDE 27

Phagemid Device Replaces Minipreps and Transformation

slide-28
SLIDE 28

Conclusions

  • Simplified biochemical manipulations using

Gateway device

  • Replaced miniprep in Gateway protocol with

lysis device

  • Further study will replace both minipreps

and transformations with phagemid-based gateway

  • Our devices simplified unit operations used

in the Gateway protocol

  • Easy to automate
  • BioCAD friendly
  • Less room for error
slide-29
SLIDE 29

Human Practices on Berkeley’s 2008 iGEM Team

slide-30
SLIDE 30
slide-31
SLIDE 31

What Can This New Form Look Like?

slide-32
SLIDE 32

Links

  • www.ars-synthetica.net
  • blogs.coe.berkeley.edu/igem
slide-33
SLIDE 33

Advisors Megan Dueck Jin Huh Terry Johnson

Acknowledgements

Berkeley iGEM Advisory Group Chris Anderson Adam Arkin John Dueber Jay Keasling Susan Marqusee Support Kevin Costa Kate Spohr Invitrogen, Inc. Logo Artwork & Design Karin Wu Human Practices Advisors Gaymon Bennett Paul Rabinow Anthony Stavrianakis Ars Synthetica Collaborators Elizabeth Ha Noah Wittman Adrian Van Allen Slideshow Interface Vuvox.com